NCT05339984 2025-06-27
LSM
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
Clinical Trials
9 trialsNCT05027425 2024-11-22
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Active not recruiting
NCT06434753 2024-06-04
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
Hospital Universitari Vall d'Hebron Research Institute
Phase 3 Recruiting
NCT02192671 2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3 Unknown
NCT05141617 2021-12-02
Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT01642446 2021-09-27
Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension
Sun Yat-sen University
Phase NA Completed
NCT04640116 2020-12-19
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
Sun Yat-sen University
Phase NA Unknown
NCT04524676 2020-08-24
Oxaliplatin-induced Portal Hypertension
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT00280007 2010-04-22
Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma
Medical University of Vienna
Phase 2 Terminated